Alnylam Pharmaceuticals, Inc. ALNY
Set alert
158.00 USD -7.00 -4.24%
At close
159.21 +1.21 +0.77%
Pre-market · Nov 3, 7:04 AM ET
156.00 Day range 163.90
156.00 52-week range 479.79
- YTD
- -60.27%
- 1 year
- -63.60%
- Open
- 163.10
- Prev close
- 165.00
- Mkt cap
- 21.16B
- Vol
- 4.76M
- Avg vol
- 1.85M
- EPS
- 19.80
- P/E
- 7.98
- Div yield
- 0.00%
More statistics
- Low
- 156.00
- High
- 163.90
- Forward P/E
- 14.17
- Beta
- 0.44
- Short ratio
- 5.02
- Inst. own
- 101.57%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2027
- 50-d avg
- 236.49
- 200-d avg
- 285.48
- 1y target
- 305.70
5D chart
Events in this range
- Oct 29, 2026Earnings: 16.26; estimate 1.66; surprise 879.52%
- Oct 30, 2026Downgrade: Bernstein · Outperform → Market Perform
- Oct 30, 2026Rating: TD Cowen · Buy → Buy
- Oct 30, 2026Rating: UBS · Buy → Buy
- Nov 2, 2026Rating: Canaccord Genuity · Buy → Buy
- Nov 2, 2026Downgrade: Truist Securities · Buy → Hold
- Nov 2, 2026Rating: Barclays · Overweight → Overweight
Signals (144)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | Nov 2, 3:55 PM | 15 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 15 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 15 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 16 hours ago |
| SMA: Bearish | Nov 2, 2:40 PM | 16 hours ago |
| MACD: Sell Signal | Nov 2, 2:40 PM | 16 hours ago |
| SMA: Bearish | Nov 2, 2:35 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 1:45 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 1:45 PM | 17 hours ago |
| MACD: Buy Signal | Nov 2, 1:45 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 1:35 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 1:35 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 1:10 PM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 1:10 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 1:05 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 12:40 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 12:30 PM | 18 hours ago |
Newest 20 of 144.
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.71B | 2.25B | 1.83B | 1.04B | 844.29M | |
| 3.03B | 1.92B | 1.52B | 868.60M | 704.14M | |
| 501.58M | -176.88M | -282.18M | -785.07M | -708.65M | |
| 313.75M | -278.16M | -440.24M | -1.13B | -852.82M | |
| 2.33 | -2.18 | -3.52 | -9.30 | -7.20 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.66B | 966.43M | 812.69M | 866.39M | 819.98M | |
| 4.97B | 4.24B | 3.83B | 3.55B | 3.64B | |
| 4.18B | 4.17B | 4.05B | 3.70B | 3.06B | |
| 2.97B | 3.14B | 2.68B | 2.61B | 2.19B | |
| 789.18M | 67.09M | -220.64M | -158.22M | 588.20M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 524.08M | -8.31M | 104.16M | -541.27M | -641.69M | |
| 436.33M | -116.84M | -336.35M | 169.35M | -273.30M | |
| -305.19M | 294.16M | 172.13M | 425.75M | 1.25B | |
| -58.70M | -34.28M | -62.21M | -72.06M | -76.37M | |
| 690.15M | 153.77M | -53.67M | 46.40M | 323.11M |